@theproof @raphaels7 @BradStanfieldMD @hubermanlab @PeterAttiaMD Glucose increase apoB-100 and saturated FFA in plaque 😉 glucose>puryvate>insulin>acetylo-CoA>cholesterol and triglycerides no thanks lol https://t.co/nGAgFmGUBW https://t.co/R2A
@dutchyankee2 @BioLayne @ScepticalDoctor apoB-100=glucose? https://t.co/nGAgFmGUBW
@CzerwoniWON Patrz i sie ucz!! Kolejny zaklad o 5 tys., czy dalej bedziesz kozaczyl? Pierwszego notarialnego zakladu nie przyjales.... Koga ja pytam, pizdy mocne w gebie, za kase juz nie chca zweryfikowac swojej wiedzy.🙉🙈🙊😈 Moge podrzucic badanie na Ludzia
Member publication alert: Therapeutic Antibody Against Phosphorylcholine Preserves Coronary Function and Attenuates Vascular 18F-FDG Uptake in Atherosclerotic Mice https://t.co/uPpdIeEgoD
RT @JACCJournals: Can phosphorylcholine-targeted therapy improve coronary artery function? A new #JACCBTS study puts this question to the t…
Can phosphorylcholine-targeted therapy improve coronary artery function? A new #JACCBTS study puts this question to the test in hypercholesterolemic mice. https://t.co/BRKvcCEm70 https://t.co/ehPpvcdNNQ
Therapeutic Antibody Against Phosphorylcholine Preserves Coronary Function and Attenuates Vascular 18F-FDG Uptake in Atherosclerotic Mice | JACC: Basic to Translational Science https://t.co/L8gE0iv7Nc
@Gearoidmuar @PakDoc @DrNadolsky @bschermd carbohydrates are the evil of this world !! 😉😈😉They are toxic to the human body, therefore they are transformed into neutral and beneficial compounds: cholesterol, FFA, IMTG, TG 🙊🙈🙉 https://t.co/nvs8Go7NAQ
RT @RoivainenAnne: Therapeutic Antibody Against Phosphorylcholine Preserves Coronary Function and Attenuates Vascular 18F-FDG Uptake in Ath…
RT @RoivainenAnne: Therapeutic Antibody Against Phosphorylcholine Preserves Coronary Function and Attenuates Vascular 18F-FDG Uptake in Ath…
Therapeutic Antibody Against Phosphorylcholine Preserves Coronary Function and Attenuates Vascular 18F-FDG Uptake in Atherosclerotic Mice https://t.co/gZQYeLE3mv
Excited to share our new study in #JACCBTS. A novel antibody treatment targeting OxPL-PC preserves coronary artery function and attenuates inflammation in atherosclerosis. @TurkuPETCentre #cvimaging A big thank you to all collaborators! https://t.co/emlQDl